CLINICAL_TRIALS
trial_result
· 2022-10-04
Clinical Trial Update: HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC [Phase 2]
Summary
Phase 2 clinical trial update investigating HGWD to improve paclitaxel-related neurotoxicity in breast cancer patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese Academy of Medical Sciences | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN